Thomas N. Wight, PhD, Co-Founder
Chief Executive Officer/President
Director, Matrix Biology Program, Benaroya Research Institute, Seattle, WA; Affiliate Professor of Pathology, University of Washington, Seattle; University of Washington faculty and Principal Investigator 28 years. Expertise in the pathology of connective and vascular tissues, including skin and blood vessels. Over 285 scientific publications. Significant experience managing faculty and staff at major research institutions.
Mervyn J. Merrilees, PhD, DSc, Co-Founder
Chief Technology Officer
Professor of Anatomy, Department of Anatomy with Radiology, School of Medical Sciences, University of Auckland, New Zealand; University of Auckland faculty and Principal Investigator for 30 years. Expertise in the structure of blood vessels, atherosclerosis, and engineering of vascular tissues. Over 70 scientific publications. Extensive University faculty and staff management experience.
Anna Lewak Wight, JD, MS
Chief Business Officer
Over 30 years of legal and business experience in pharmaceuticals, former VP Legal Poniard Pharmaceuticals, Seattle, WA; Partner, Morrison and Foerster, Seattle, WA; Partner, Harness Dickey and Pierce, Troy, MI. Extensive experience in intellectual property and product rights procurement, management, and divestiture,
and in pharmaceutical and corporate activities. Licensed to practice in Washington, Michigan, and before USPTO.
Ingrid A. Harten, PhD
Director of Research
Scientist Benaroya Research Institute and Matrexa, Seattle,WA; President/Co-owner, Elefteria, Inc., Snohomish, WA. Experience in both basic research and small business administration. Research focus in cardiovascular pathology and cell biology of aging with seven scientific publications.